Investor deadline approaching: faruqi & faruqi, llp investigates claims on behalf of investors of regeneron pharmaceuticals

Faruqi & faruqi, llp securities litigation partner james (josh) wilson encourages investors who suffered losses exceeding $100,000 in regeneron to contact him directly to discuss their options if you purchased or acquired securities in regeneron between november 2, 2023 and october 30, 2024 and would like to discuss your legal rights, call faruqi & faruqi partner josh wilson directly at 877-247-4292 or 212-983-9330  (ext. 1310). [you may also click here for additional information] new york , jan. 23, 2025 /prnewswire/ -- faruqi & faruqi, llp, a leading national securities law firm, is investigating potential claims against regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn) and reminds investors of the march 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the company.
REGN Ratings Summary
REGN Quant Ranking